Synthesis and anticancer activity evaluation of (E)-3-{[5-(aryl)-1,3,4-oxadiazol-2-yl]methyl}-5-(3,4,5-trimethoxybenzylidene)thiazolidine-2,4-diones
- Authors: Ashok D.1, Vanaja B.1
-
Affiliations:
- Green and Medicinal Chemistry Laboratory, Department of Chemistry
- Issue: Vol 86, No 3 (2016)
- Pages: 681-685
- Section: Article
- URL: https://journals.rcsi.science/1070-3632/article/view/214366
- DOI: https://doi.org/10.1134/S1070363216030270
- ID: 214366
Cite item
Abstract
A series of new substituted (E)-3-{[5-(aryl)-1,3,4-oxadiazol-2-yl]methyl}-5-(3,4,5-trimethoxy-benzylidene) thiazolidine-2,4-diones have been synthesized. The products have been characterized by their IR, 1H NMR, 13C NMR, and mass spectral properties and evaluated for anticancer activity against four human cancer cell lines: A549, A375, MCF-7, and HT-29.
Keywords
About the authors
D. Ashok
Green and Medicinal Chemistry Laboratory, Department of Chemistry
Author for correspondence.
Email: ashokdou@gmail.com
India, Hyderabad, 500007
B. Vanaja
Green and Medicinal Chemistry Laboratory, Department of Chemistry
Email: ashokdou@gmail.com
India, Hyderabad, 500007